Search results
AFT Pharmaceuticals Limited (NZSE:AFT) Just Reported Yearly Earnings: Have Analysts Changed Their...
Simply Wall St. via Yahoo Finance· 1 day agoThere are some variant perceptions on AFT Pharmaceuticals, with the most bullish analyst valuing it...
Assetmark Inc. Has $2.21 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
ETF DAILY NEWS· 15 hours agoAssetmark Inc. raised its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 14.7% in the 4th quarter, according to the company ...
Jump Financial LLC Has $300,000 Stake in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA)
ETF DAILY NEWS· 18 hours agoJump Financial LLC reduced its stake in shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 43.7% during the 4th quarter, according to ...
Russell Investments Group Ltd. Has $359,000 Stock Holdings in Phathom Pharmaceuticals, Inc....
ETF DAILY NEWS· 4 days agoRussell Investments Group Ltd. lifted its stake in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) by 178.3% in the fourth quarter, according ...
Vertex CEO Kewalramani sells over $6.7 million in company stock By Investing.com
Investing.com· 4 days agoVertex Pharmaceuticals (NASDAQ:VRTX) Incorporated (NASDAQ:VRTX) CEO and President Reshma Kewalramani...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 2 days agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Victory Capital Management Inc. Raises Position in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)
ETF DAILY NEWS· 2 days agoVictory Capital Management Inc. raised its holdings in shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 35.1% in the 4th quarter, according ...
It's Probably Less Likely That ACADIA Pharmaceuticals Inc.'s (NASDAQ:ACAD) CEO Will See A Huge Pay...
Simply Wall St. via Yahoo Finance· 4 days agoComparing ACADIA Pharmaceuticals Inc.'s CEO Compensation With The Industry According to our data,...
Is Madrigal Pharmaceuticals Stock a Buy?
The Motley Fool via AOL· 5 days agoFurther, Rezdiffra's indication does not require that patients undertake a liver biopsy, a procedure many may have avoided. Rezdiffra is a once-daily...
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Stock Position Reduced by Swiss National Bank
ETF DAILY NEWS· 3 days agoSwiss National Bank trimmed its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 10.1% in the fourth quarter, according to its ...
